Manning Paul B

CIK 00014946959 companiesNEEDHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001494695

Recent Transactions

50 trades

Purchase
Candel Therapeutics, Inc.$CADL
Common Stock
2026-02-23$5.45/sh+550,458→ 2,763,527 total
Other
Liquidia Corp$LQDA
Common Stock
2026-02-11$42.63/sh+55,116→ 469,583 total
Other
Liquidia Corp$LQDA
Common Stock
2026-02-11$42.63/sh−55,116→ 0 total
Purchase
Verrica Pharmaceuticals Inc.$VRCA
Series C Warrant (right to buy)
2025-11-25+343,845→ 343,845 total
Purchase
Verrica Pharmaceuticals Inc.$VRCA
Common Stock
2025-11-25$4.24/sh+2,750,762→ 3,348,372 total
Purchase
Verrica Pharmaceuticals Inc.$VRCA
Common Stock
2025-11-25$4.24/sh+1,375,380→ 3,958,189 total
Purchase
Verrica Pharmaceuticals Inc.$VRCA
Series C Warrant (right to buy)
2025-11-25+687,690→ 687,690 total
Sale
Liquidia Corp$LQDA
Common Stock
2025-09-02$29.14/sh−74,230→ 430,828 total
Sale
Liquidia Corp$LQDA
Common Stock
2025-09-02$28.67/sh−254,038→ 505,058 total
Sale
Liquidia Corp$LQDA
Common Stock
2025-08-29$27.62/sh−188,232→ 759,096 total
Sale
Liquidia Corp$LQDA
Common Stock
2025-08-28$27.94/sh−154,337→ 947,328 total
Award
Candel Therapeutics, Inc.$CADL
Common Stock
2025-06-25$4.67/sh+1,070,663→ 2,213,069 total
Award
Liquidia Corp$LQDA
Common Stock
2025-06-17+18,396→ 38,755 total
Award
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2025-06-17+14,240→ 14,240 total
Purchase
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2025-05-30$2.75/sh+750,000→ 2,841,704 total
Purchase
Candel Therapeutics, Inc.$CADL
Common Stock
2024-12-16$6.00/sh+500,000→ 1,142,406 total
Purchase
Candel Therapeutics, Inc.$CADL
Common Stock
2024-12-16$6.00/sh+750,000→ 1,303,752 total
Gift
Verrica Pharmaceuticals Inc.$VRCA
Common Stock
2024-11-26−450,000→ 25,828,094 total
Purchase
Verrica Pharmaceuticals Inc.$VRCA
Common Stock
2024-11-22+4,494,382→ 5,976,101 total
Purchase
Verrica Pharmaceuticals Inc.$VRCA
Series A Warrants (right to buy)
2024-11-22+2,247,191→ 2,247,191 total
Purchase
Verrica Pharmaceuticals Inc.$VRCA
Series B Warrants (right to buy)
2024-11-22+9,213,483→ 9,213,483 total
Purchase
Verrica Pharmaceuticals Inc.$VRCA
Common Stock
2024-11-22+18,426,966→ 26,278,094 total
Purchase
Verrica Pharmaceuticals Inc.$VRCA
Series A Warrants (right to buy)
2024-11-22+9,213,483→ 9,213,483 total
Purchase
Verrica Pharmaceuticals Inc.$VRCA
Series B Warrants (right to buy)
2024-11-22+2,247,191→ 2,247,191 total
Gift
Verrica Pharmaceuticals Inc.$VRCA
Common Stock
2024-09-19−2,675,611.25→ 0 total
Gift
Verrica Pharmaceuticals Inc.$VRCA
Common Stock
2024-09-19+891,870.42→ 891,870.42 total
Gift
Verrica Pharmaceuticals Inc.$VRCA
Common Stock
2024-09-19+891,870.42→ 891,870.42 total
Gift
Verrica Pharmaceuticals Inc.$VRCA
Common Stock
2024-09-19+891,870.41→ 891,870.41 total
Purchase
Liquidia Corp$LQDA
Common Stock
2024-09-12$8.90/sh+337,078→ 816,311 total
Purchase
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2024-06-27$2.25/sh+1,333,333→ 1,333,333 total
Award
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2024-06-26+14,240→ 14,240 total
Award
Liquidia Corp$LQDA
Common Stock
2024-06-20+20,359→ 299,689 total
Purchase
Liquidia Corp$LQDA
Common Stock
2023-12-14$7.16/sh+279,330→ 279,330 total
Purchase
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2023-11-17$1.63/sh+100,000→ 16,566,667 total
Purchase
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2023-08-16$0.90/sh+16,466,667→ 16,466,667 total
Purchase
Verrica Pharmaceuticals Inc.$VRCA
Common Stock
2023-07-24$5.02/sh+200,000→ 7,851,128 total
Award
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2023-06-28+14,240→ 14,240 total
Award
Liquidia Corp$LQDA
Non-Qualified Stock Option (right to buy)
2023-06-19+20,000→ 20,000 total
Purchase
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2022-10-31$2.00/sh+1,500,000→ 1,642,202 total
Award
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2022-10-13+14,240→ 14,240 total
Purchase
Verrica Pharmaceuticals Inc.$VRCA
Common Stock
2022-07-05$2.10/sh+4,761,904→ 13,651,128 total
Award
Taysha Gene Therapies, Inc.$TSHA
Stock Option (right to buy)
2022-06-17+15,500→ 15,500 total
Award
Liquidia Corp$LQDA
Non-Qualified Stock Option (right to buy)
2022-06-17+20,000→ 20,000 total
Purchase
Liquidia Corp$LQDA
Common Stock
2022-04-18$5.10/sh+392,156→ 392,156 total
Award
Liquidia Corp$LQDA
Common Stock
2022-03-31+435,674→ 435,674 total
Purchase
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2022-02-03$7.84/sh+26,602→ 2,091,704 total
Purchase
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2022-02-03$7.84/sh+50,000→ 142,202 total
Purchase
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2022-02-02$7.77/sh+58,000→ 92,202 total
Purchase
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2022-02-02$7.77/sh+22,000→ 22,000 total
Purchase
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2022-02-02$7.77/sh+45,000→ 2,065,102 total

Manning Paul B

Recent Transactions

Companies

Recent Filings

Address